- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed and Refractory Follicular Lymphoma
Total 59493 results
-
Gilead SciencesCompletedFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; Seagen Inc.WithdrawnBrentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell LymphomaRecurrent Angioimmunoblastic T-Cell Lymphoma | Refractory Angioimmunoblastic T-Cell Lymphoma | Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified | Recurrent Enteropathy-Associated T-Cell Lymphoma | Recurrent Follicular T-Cell Lymphoma | Recurrent Hepatosplenic T-Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Clinica Universidad de Navarra, Universidad de...Spanish National Health SystemUnknownFollicular Lymphoma | Follicular Non-Hodgkin´s Lymphoma | Autologous Effector LymphocytesSpain
-
SecuraBioWithdrawnFollicular Lymphoma | Marginal Zone Lymphoma | Small Lymphocytic Lymphoma | Indolent Non-Hodgkin's LymphomaUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI); Genentech, Inc.RecruitingDiffuse Large B-Cell Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Primary Mediastinal (Thymic) Large B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Follic Lymph to Diff Large B-Cell Lymphoma | Transformed Marg Zone Lymph to Diff...United States
-
Shanghai General Hospital, Shanghai Jiao Tong University...RecruitingRefractory Lymphoma | Refractory Leukemia | Efficacy, Self | T-lymphoblastic Lymphoma | Safety | Relapsed DiseaseChina
-
Institute of Hematology and Blood Transfusion,...RecruitingNon-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma Refractory | Relapsed or Refractory B-cell Acute Lymphoblastic LeukemiaCzechia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingFatigue | Weight Loss | Fever | Splenomegaly | Ann Arbor Stage II Grade 1 Follicular Lymphoma | Ann Arbor Stage II Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1... and other conditionsUnited States
-
National Cancer Institute (NCI)TerminatedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic... and other conditionsUnited States
-
University of WashingtonNational Cancer Institute (NCI)CompletedGrade 3b Follicular Lymphoma | Stage III Follicular Lymphoma | Composite Lymphoma | Stage I Diffuse Large B-Cell Lymphoma | Stage I Follicular Lymphoma | Stage II Diffuse Large B-Cell Lymphoma | Stage II Follicular Lymphoma | Stage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell Lymphoma and other conditionsUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed/Refractory Mantle Cell Lymphoma | Relapsed/Refractory B-precursor Acute Lymphoblastic LeukemiaJapan
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Splenic Marginal Zone Lymphoma | Waldenström Macroglobulinemia and other conditionsUnited States
-
Novartis PharmaceuticalsRecruitingFollicular Lymphoma | Acute Lymphoblastic Leukemia | Diffuse Large B-cell LymphomaBrazil
-
Curis, Inc.The Leukemia and Lymphoma SocietyCompletedLymphoma | Refractory Lymphoma | Relapsed Lymphoma | Relapsed and/or Refractory Lymphoma | Relapsed Ddiffuse Large B-Cell Lymphoma (DLBCL) | Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Relapsed and/or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) | Double-hit Lymphoma (DHL) | Triple-hit Lymphoma... and other conditionsUnited States
-
Gilead SciencesTerminatedFollicular Lymphoma | Marginal Zone Lymphoma | Chronic Lymphocytic Leukemia | Small Lymphocytic LymphomaUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Not yet recruitingFollicular LymphomaChina
-
The Lymphoma Academic Research OrganisationGrupo Español de Linfomas y Transplante Autólogo de Médula Ósea; Swiss Group... and other collaboratorsRecruitingFollicular LymphomaBelgium, France, Germany, Portugal, Spain
-
Power Life Sciences Inc.Not yet recruitingFollicular LymphomaUnited States
-
Vaishalee KenkreEpizyme, Inc.; University of Wisconsin, MadisonRecruitingFollicular LymphomaUnited States
-
The Lymphoma Academic Research OrganisationRoche Pharma AGRecruitingFollicular LymphomaFrance
-
Washington University School of MedicineGenentech, Inc.; Institute for Follicular LymphomaRecruitingLymphoma, Follicular | Follicular LymphomaUnited States
-
Sunnybrook Health Sciences CentreRecruiting
-
Juan P. Alderuccio, MDADC Therapeutics S.A.RecruitingFollicular LymphomaUnited States
-
Wuhan UniversityRecruitingFollicular LymphomaChina
-
Pharmacyclics LLC.Active, not recruitingFollicular LymphomaUnited Kingdom, Portugal, Taiwan, Spain, Belgium, Netherlands, Israel, United States, Czechia, Italy, France, Hungary, Australia, Poland, Canada, Austria, Russian Federation, Greece, Turkey
-
Hoffmann-La RocheCompletedFollicular LymphomaItaly
-
Dana-Farber Cancer InstituteActive, not recruitingFollicular LymphomaUnited States
-
The Lymphoma Academic Research OrganisationCelgene CorporationActive, not recruitingFollicular LymphomaSpain, Canada, France, Australia, Italy, Belgium, Germany, Portugal
-
Swiss Group for Clinical Cancer ResearchNordic Lymphoma GroupTerminatedFollicular LymphomaSweden, Finland, Denmark, Norway, Switzerland, Austria
-
Ludwig-Maximilians - University of MunichBayer; Roche Pharma AGActive, not recruiting
-
Olivia Newton-John Cancer Research InstituteAustin Health; Roche Products Pty Limited; Ballarat Health ServicesActive, not recruitingFollicular LymphomaAustralia
-
Xynomic Pharmaceuticals, Inc.Active, not recruitingFollicular LymphomaSpain, United States, France
-
Dr. Reddy's Laboratories LimitedParexelCompleted
-
SecuraBioTerminatedFollicular LymphomaFrance, Italy, Australia, Poland
-
Fondazione Italiana Linfomi - ETSTerminatedFollicular LymphomaItaly
-
Dr. Eliza HawkesBristol-Myers SquibbActive, not recruitingFollicular LymphomaAustralia
-
Swiss Group for Clinical Cancer ResearchCompletedFollicular LymphomaSwitzerland
-
SandozNovartis PharmaceuticalsCompletedFollicular LymphomaRussian Federation, Netherlands, Peru, United Kingdom, Romania, Brazil, Malaysia, Spain, India, Italy, Bulgaria, Poland, South Africa, Japan, Argentina, Australia, Austria, Colombia, France, Germany, Greece, Hungary, Ireland, Israel, Po... and more
-
Lars Møller PedersenCompletedFollicular LymphomaDenmark
-
Millennium Pharmaceuticals, Inc.CompletedFollicular LymphomaUnited States, United Kingdom, Belgium, Canada
-
The Christie NHS Foundation TrustBayerCompletedFollicular LymphomaUnited Kingdom, France
-
Merck Sharp & Dohme LLCTerminatedFollicular Lymphoma
-
The Lymphoma Academic Research OrganisationTerminated
-
Weill Medical College of Cornell UniversityGilead SciencesTerminatedFollicular LymphomaUnited States
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineTerminatedFollicular LymphomaUnited States
-
Sunnybrook Health Sciences CentreCompletedFollicular LymphomaCanada
-
Fondazione Italiana Linfomi ONLUSCentro di Riferimento per l'Epidemiologia e la Prev. Oncologica PiemonteCompleted
-
Hoffmann-La RocheCompleted
-
St. Louis UniversityCompletedFollicular LymphomaUnited States